07 Jan 2022
Levoketoconazole, which inhibits cortisol synthesis, has been approved by the US Food and Drug Administration for treating Cushing syndrome.
Call for nominations for Awards Committee Chair
30 Oct 2024
James M Tanner Award - 2025 nominations open
30 Oct 2024
Would you like to host the BSPED annual meeting?
21 Oct 2024